Japanese version of “Amicus Curiae”

Subjective Requirements for Indirect Infringement by Products Not Exclusively Used for Patent Infringement

Prior Use Right – Modification to Accused Product/Method and Amendment to Patent Claim

Interpretation of Article 102 of Patent Act under 2019 Amendments

「Recent trend on JPO appeal and IPHC decisions (Chemistry)」

Third Party Opinion Solicitation System Introduced by the Amended Patent Act in the Era of Artificial Intelligence (AI) and IoT

Online Participation in Oral Proceedings Will be Possible as of October 1, 2021

Affixation of Seal or Signature Is No Longer Required for Most Procedures as of June 12, 2021

Patent Registration and Maintenance Fees Raised as of April 1, 2022

「Recent trend on JPO appeal decisions and IPHC Decisions (Chemistry)」

MORIMOTO, Takayuki (Ph.D.)

Our firm and attorneys received high evaluation at “2021 edition of IAM Patent 1000”.

「Does a third party infringe a patent right by conducting clinical trials on an original drug?」

YUASA and HARA has been ranked Tier 1 for Patent Prosecution & Contentious and Trademark Prosecution by Managing Intellectual Property in 2021

Attorneys of our firm received high evaluation at “Best Lawyers in Japan (2021)”.

「Recent trend on JPO appeal decisions and Court Decisions (Chemistry)」

9th Annual Waseda Global Patent Law Conference

YUASA and HARA has been selected as one of the tier 1 firm for areas of patent prosecution of “The 2020 Asia IP Patent Rankings” sponsored by “Asia IP.”

CRISPR-Cas9 Gene editing system, non-complex technology; complex patenting

YOKO, Taro

Antibody Patenting: U.S. and Asian Perspectives – Meeting Patentability Requirements in the USPTO, JPO, and CNIPA

「The IPR Gorilla Virtual Conference July 14 – 15, 2020」 Presentation: Recent Topics on Japanese Patent Practice

YUASA and HARA has been ranked Tier 1 for Patent and Trademark Prosecution and Contentious by Managing Intellectual Property in 2020

“Assessment of inventive steps when a differentiating feature has multiple technical meanings – positioning of remarkable effects –”

MUTO, Yoko

INOUE, Kazuma

Functionally-claimed antibody patent – the Amgen v Sanofi case

New Patent Fee Reduction/Exemption Program Including Academic Discount Has Been launched since April 1, 2019

Recent trend on JPO appeal decisions and Court Decisions (Chemistry)

MIYAWAKI, Kaoru